Are you a new member? Sign up now
Login area
| Sign up
close
VECTIBIX - 400mg/20ml - 1 x 20ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FE02 | BioTech | Panitumumab - 400mg/20ml | 7237 | 187460/13 | VECTIBIX | 400mg/20ml | 1 x 20ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | 147,763,999 L.L | 2.44 | E2 | Amgen Europe BV | The Netherlands | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FE02 | BioTech | Panitumumab - 400mg/20ml | 7237/388 | 187460/13 | VECTIBIX | 400mg/20ml | 1 x 20ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | L.L | 2.44 | E2 | Amgen Europe BV | The Netherlands | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024